middle.news
How Will Algorae’s New Cadila Deal Transform Its ANZ Market Reach?
9:12am on Monday 9th of February, 2026 AEDT
•
Pharmaceuticals
Read Story
How Will Algorae’s New Cadila Deal Transform Its ANZ Market Reach?
9:12am on Monday 9th of February, 2026 AEDT
Key Points
Licence & Supply Agreement signed with Cadila for two generic cardiovascular and metabolic drugs
Algorae to manage TGA sponsorship and commercialisation via AlgoraeRx
Partnership complements existing oncology licensing and distribution deals
Cadila responsible for product development and manufacturing
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
ALGORAE PHARMACEUTICALS (ASX:1AI)
OPEN ARTICLE